Fed. Circ. Judge Unsure IP At Heart Of $1.1B Juno Win Is Valid
By Britain Eakin ( July 6, 2021, 8:46 PM EDT) -- The Federal Circuit's chief judge appeared receptive Tuesday to Kite Pharma's argument that a Juno Therapeutics drug patent is too broad to be valid, potentially calling into question Juno's more than $1.1 billion infringement win during the appellate court's first in-person hearing since the arrival of the COVID-19 pandemic....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.